Kardium Inc.

Kardium Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Kardium is developing a revolutionary medical device for the diagnosis and treatment of atrial fibrillation. .

Company Details

Employees
416
Founded
-
Address
8518 Glenlyon Pkwy, 155,canada
Phone
(604)248-8891
Email
in****@****ium.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Burnaby, BC
Looking for a particular Kardium Inc. employee's phone or email?

Kardium Inc. Questions

News

Kardium Announces $250M (CA$340M) Financing to Launch Innovative Atrial Fibrillation Treatment - Business Wire

Kardium Announces $250M (CA$340M) Financing to Launch Innovative Atrial Fibrillation Treatment Business Wire

Kardium receives FDA OK for pulsed field ablation system - medtechdive.com

Kardium receives FDA OK for pulsed field ablation system medtechdive.com

Kardium Raises $250M in Funding - FinSMEs

Kardium Raises $250M in Funding FinSMEs

Kardium Announces First Commercial Procedures with the Globe® Pulsed Field System, the World’s Most Advanced Solution for Atrial Fibrillation - Business Wire

Kardium Announces First Commercial Procedures with the Globe® Pulsed Field System, the World’s Most Advanced Solution for Atrial Fibrillation Business Wire

FDA approval marks “most significant milestone” in Kardium’s history - BetaKit

FDA approval marks “most significant milestone” in Kardium’s history BetaKit

QIA invests in innovative healthcare company, Kardium - The Peninsula Qatar

QIA invests in innovative healthcare company, Kardium The Peninsula Qatar

Kardium receives FDA approval of the Globe® Pulsed Field System - Business Wire

Kardium receives FDA approval of the Globe® Pulsed Field System Business Wire

FDA clears Kardium Globe pulsed field ablation system - Cardiovascular Business

FDA clears Kardium Globe pulsed field ablation system Cardiovascular Business

Kardium grabs FDA approval for Globe pulsed field ablation catheter in afib - Fierce Biotech

Kardium grabs FDA approval for Globe pulsed field ablation catheter in afib Fierce Biotech

Kardium receives US FDA approval for Globe pulsed field ablation system - Cardiac Rhythm News

Kardium receives US FDA approval for Globe pulsed field ablation system Cardiac Rhythm News

PULSAR gives Kardium legs in PFA horse race - BioWorld MedTech

PULSAR gives Kardium legs in PFA horse race BioWorld MedTech

Kardium gets FDA green light for Globe pulsed field ablation system - MassDevice

Kardium gets FDA green light for Globe pulsed field ablation system MassDevice

Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe PF System - Business Wire

Kardium Announces 1-Year PULSAR IDE Study Results for Its PFA Device – the Globe PF System Business Wire

Kardium pulls in an additional $250M to advance PFA tech - medtechdive.com

Kardium pulls in an additional $250M to advance PFA tech medtechdive.com

Kardium raises $250M as its pulsed field ablation system undergoes FDA review - Fierce Biotech

Kardium raises $250M as its pulsed field ablation system undergoes FDA review Fierce Biotech

Kardium beats expectations with $250M haul - BioWorld MedTech

Kardium beats expectations with $250M haul BioWorld MedTech

Field Medical, Kardium announce funding rounds to boost PFA systems - Cardiac Rhythm News

Field Medical, Kardium announce funding rounds to boost PFA systems Cardiac Rhythm News

Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment - Business Wire

Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment Business Wire

Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study - Business Wire

Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study Business Wire

Kardium’s Globe System Begins Clinical Trial at St. Paul's Hospital - Business Wire

Kardium’s Globe System Begins Clinical Trial at St. Paul's Hospital Business Wire

PV Isolation Using a Spherical Array PFA Catheter: Application Repetition and Lesion Durability (PULSE-EU Study) - ScienceDirect.com

PV Isolation Using a Spherical Array PFA Catheter: Application Repetition and Lesion Durability (PULSE-EU Study) ScienceDirect.com

Kardium raises $250M to support pulsed field ablation system - MassDevice

Kardium raises $250M to support pulsed field ablation system MassDevice

Kardium raises $104M to develop pulsed field ablation system - medtechdive.com

Kardium raises $104M to develop pulsed field ablation system medtechdive.com

Kardium reports first commercial cases with Globe PFA - MassDevice

Kardium reports first commercial cases with Globe PFA MassDevice

Kardium’s Globe PFA system gains FDA approval - BioWorld MedTech

Kardium’s Globe PFA system gains FDA approval BioWorld MedTech

Kardium nets $104M for its spherical pulsed field ablation catheter - Fierce Biotech

Kardium nets $104M for its spherical pulsed field ablation catheter Fierce Biotech

Kardium shares 1-year Globe pulsed field ablation data - MassDevice

Kardium shares 1-year Globe pulsed field ablation data MassDevice

Kardium Receives CE Mark for Globe® Mapping and Ablation System - Business Wire

Kardium Receives CE Mark for Globe® Mapping and Ablation System Business Wire

Kardium gets FDA greenlight to sell in the U.S. device that treats common heart problem - The Globe and Mail

Kardium gets FDA greenlight to sell in the U.S. device that treats common heart problem The Globe and Mail

B.C. medtech Kardium lands US$250M to bring heart-rhythm device to market - Business in Vancouver

B.C. medtech Kardium lands US$250M to bring heart-rhythm device to market Business in Vancouver

Kardium raises $340-million as B.C. heart device maker prepares for FDA approval, market entry - The Globe and Mail

Kardium raises $340-million as B.C. heart device maker prepares for FDA approval, market entry The Globe and Mail

Kardium Marks First Commercial Procedures of Globe® Mapping and Ablation System - Business Wire

Kardium Marks First Commercial Procedures of Globe® Mapping and Ablation System Business Wire

QIA Joins USD 250M for Canada’s Kardium to Launch AFib Treatment - waya.media

QIA Joins USD 250M for Canada’s Kardium to Launch AFib Treatment waya.media

Kardium closes $340 million CAD to secure regulatory approval, expand manufacturing for atrial fibrillation heart device - BetaKit

Kardium closes $340 million CAD to secure regulatory approval, expand manufacturing for atrial fibrillation heart device BetaKit

Kardium secures $143 million CAD to help bring irregular heartbeat treatment to market - BetaKit

Kardium secures $143 million CAD to help bring irregular heartbeat treatment to market BetaKit

Kardium Announces Successful Results From GLOBAL-AF Study - Diagnostic and Interventional Cardiology

Kardium Announces Successful Results From GLOBAL-AF Study Diagnostic and Interventional Cardiology

B.C. heart device firm Kardium founded by Creo executives raises $115-million from Fidelity, T. Rowe Price ahead of going public - The Globe and Mail

B.C. heart device firm Kardium founded by Creo executives raises $115-million from Fidelity, T. Rowe Price ahead of going public The Globe and Mail

BC’s Kardium raises $115 million USD for heart device technology - BetaKit

BC’s Kardium raises $115 million USD for heart device technology BetaKit

Top Kardium Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant